Ana Tediosi

Company: WEP Clinical

Job title: Director & Head of Expanded Access Program Strategy & Business Development

Seminars:

Market Trends- Optimizing Post-Trial Access (PTA): Why the Pharmaceutical Industry is Streamlining PTA Processes 12:00 pm

Continuing the treatment after the closure of the clinical trial is more than a regulatory requirement- it’s a lifeline for patients who depend on investigational treatments. By streamlining PTA processes, pharmaceutical companies can deliver faster access to therapies, improve patient outcomes, and enhance operational efficiency Despite its importance, PTA remains underutilized. Many companies still rely…Read more

day: Day 1